Early research (Phase 1)Looking for participantsNCT06128148
What this trial is testing
Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
Who this might be right for
Protein Kinase InhibitorsOther Protocol Specified CriteriaLung Neoplasms+1 more
Guangzhou JOYO Pharma Co., Ltd 101